Ivabradine and outcomes in chronic heart failure.
- 1 December 2010
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 376 (9758), 2069-70
- https://doi.org/10.1016/S0140-6736(10)62286-6
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- A case of inappropriate sinus tachycardia after atrio-ventricular nodal reentrant tachycardia cryoablation successfully treated by ivabradineEP Europace, 2010
- Left bundle branch block and mortality in patients with acute heart failure syndrome: a substudy of the EFICA cohortEuropean Journal of Heart Failure, 2010
- Rationale and design of a randomized, double‐blind, placebo‐controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)European Journal of Heart Failure, 2009
- Influence of left bundle branch block on long-term mortality in a population with heart failureEuropean Heart Journal, 2007